TIGIT and neoplasm: In several tumor entities, including lung adenocarcinoma, the expression of this regulatory receptor was found to be increased on TILs, giving tumor cells an additional option to escape the immune system in suppressing the functions of the TILs, when TIGIT binds one of its ligands Nectin-2 or PVR [17].